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Abstract
Background: Silicosis features foci of inflammation where macrophages and lymphocytes precede
and accompany fibroblast proliferation, alveolar epithelial hyperplasia, and increased deposition of
connective tissue matrix material. In the mouse following silica inhalation there is recruitment of
natural killer-, B-, and CD4+ and CD8+ lymphocytes to the alveolar spaces, enlargement of
bronchial-associated lymphoid tissues (BALT), and aggregation of lymphocytes surrounding small
airways and blood vessels. A substantial fraction of the recruited lung lymphocytes produce
interferon-γ (IFN-γ), and IFN-γ gene-deleted mice develop less silicosis than wild-type mice.
Interleukin-12 (IL-12) is an important pathway for driving the adaptive immune response towards
a TH1-like phenotype. We hypothesized that IL-12 might stimulate lymphocyte activation and the
up-regulation of IFN-γ, and consequently be an essential mediator for silicosis.
Results: C57Bl/6 wild-type (WT) and IL-12 deficient (IL-12 KO) mice were exposed to sham-air
or crystobalite silica (61 mg/m3) by inhalation for 5 hours/day for 12 days and then studied from 1
to 112 days after exposure. Mice exposed to sham-air had normal lung histology at all time points.
WT mice exposed to titanium dioxide (72 mg/m3) showed pulmonary macrophage recruitment but
no increase in lung collagen. Both WT and IL-12 KO mice exposed to silica showed similar
progressive lung pathology, increased wet lung weight and increased total lung collagen
(hydroxyproline). IL-12 p35 mRNA was not increased in either strain after silica exposure; IL-12
p40 mRNA was up-regulated after silica in WT mice and constitutively absent in the IL-12 KO mice.
IL-18 mRNA was not increased after silica exposure. The expression of IL-15 (an important driver
for innate immunity, Natural Killer cell activation, and IFN-γ production) was abundant in air-
exposed mice and was increased slightly in the lungs of mice with silicosis.
Conclusion: The axis of IL-12 driving IFN-γ production is not essential for the full manifestations
of silicosis in mice exposed to a crystobalite silica aerosol.
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Background
Silicosis is a chronic diffuse parenchymal lung disease
caused by the inhalation of respirable particles of crystal-
line silica. In the lung, foci of inflammation featuring
macrophages and lymphocytes precede and accompany
fibroblast proliferation, alveolar epithelial hyperplasia,
and increased deposition of connective tissue matrix
material. The mechanisms through which silica triggers
these responses have been clarified over the past four dec-
ades, but many key pathways remain unknown [1-7]. We
have used mice exposed to silica by inhalation as a test
system to elucidate some of these pathways [8]. In partic-
ular, we have focused on cytokines produced by macro-
phages that may recruit and activate lymphocytes and
fibroblasts, and cytokines produced by lymphocytes that
may in turn activate macrophages and modify fibroblast
function [9-14].
Lymphocytes are a prominent feature of the lung lesions
of silicosis, both in man and in experimental rodents. In
the mouse following silica inhalation there is prompt and
persistent recruitment of lymphocytes to the alveolar
spaces, enlargement of bronchial-associated lymphoid tis-
sues (BALT), and aggregation of lymphocytes surrounding
small airways and blood vessels [14]. These recruited lung
lymphocytes include natural killer (NK) cells, B-cells,
CD4+ T-cells, and CD8+ T-cells in greatly increased num-
bers but in proportions similar to those in the normal
mouse lung [12,15].
A substantial fraction of the recruited lung lymphocytes in
murine silicosis produce interferon-γ (IFN-γ). The num-
bers of cells containing IFN-γ protein, the abundance of
mRNA for IFN-γ, and the frequency of sites with cells con-
taining mRNA for IFN-γ in situ are increased [11]. Con-
versely, the abundance of interleukin-4 (IL-4) appears to
be relatively decreased in this inhalation model system.
Mice that constitutively lack IFN-γ production (C57Bl/6-
Ifng1Ts) develop less extensive lung pathology and less
lung collagen deposition early after silica inhalation [14].
These observations suggest that silicosis resembles the TH1
type of response described for the adaptive immune
response, or a similar TH1-like response that is important
for the innate response. The exact roles for IFN-γ remain
uncertain, since this cytokine could act early in the
response to silica to recruit and activate macrophages and
lymphocytes [16,17]. IFN-γ might also act later in silicosis
to down-regulate fibroblast responses to transforming
growth factor-β (TGF-β) and decrease collagen production
[18-22].
Interleukin-12 (IL-12) is an important macrophage-
derived cytokine that can drive IFN-γ production [23]. The
mature biologically active IL-12 protein is a heterodimer
composed of a p35 subunit and a p40 subunit that are
assembled to produce the secreted p70 form. An increase
in IL-12 is a prime determinant that biases uncommitted
(TH0) lymphocytes towards a TH1-type response in anti-
gen-driven adaptive immunity, and IL-12 is an essential
cytokine for an effective response to intracellular micro-
bial pathogens. Monomers or dimers (p80) of the IL-12
p40 peptide have distinct activities. Interleukin-18 aug-
ments but cannot replace the actions of IL-12 on IFN-γ
production [24-26].
Interleukin-15 (IL-15) is produced in the bone marrow
and by a variety of lymphoid and mesenchymal cells in
peripheral organs. IL-15 is critical for the bone marrow
proliferation of NK cells and for the peripheral organ acti-
vation of NK cells [27-31]. IL-15 offers an alternative stim-
ulus which can up-regulate IFN-γ production in NK cells
and T-cells, and appears to be a key cytokine in the innate
immune response.
We hypothesized that silica might stimulate macrophages
to produce IL-12, and possibly IL-18, and that these
cytokines would be essential factors in generating IFN-γ.
We postulated that when mice lacking the ability to pro-
duce IL-12 were exposed to silica they would develop less
IFN-γ production, less mononuclear cell inflammation,
and less lung collagen accumulation than wild-type IL-12-
sufficient mice. We tested this hypothesis by exposing to
silica a strain of genetically modified mice wherein the IL-
12 p40 gene had been deleted (IL-12 KO; B6.129S1-Il12b
tm1jm) [32,33]. The hypothesis proved to be incorrect. The
IL-12 KO mice and the C57Bl/6 wild-type mice exposed to
silica developed comparable lung pathology, lung colla-
gen accumulation, and up-regulation of IFN-γ mRNA
expression. Mice exposed to sham-air or to the inert parti-
cle titanium dioxide (TiO2) had normal lungs and served
as comparisons for the silica-exposed mice. Thus IL-12
signaling was not essential in silicosis and alternative
pathways to a TH1-like innate response may be more
important.
Results
Growth and general health
All mice from both C57Bl/6 and IL-12 KO strains
appeared to be healthy and showed normal behavior
regardless of exposure to sham-air or inhalation of cristo-
balite silica or titanium dioxide for 5 hours per day for 12
days. There were no unplanned deaths among the mice.
All of the mice gained weight normally and similarly;
mice at 1 day post-exposure averaged 22.4 g ± 2.2 g (mean
± SD) and mice at 112 days weighed 31.4 g ± 2.3 g, a 40%
weight gain, with no differences among groups at any
time point.Particle and Fibre Toxicology 2006, 3:2 http://www.particleandfibretoxicology.com/content/3/1/2
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Lung pathology
Wild-type C57Bl/6 mice exposed to sham-air had lungs
which demonstrated normal histology at all time points
throughout the 16 weeks of study; a representative lung
section is shown in Figure 1A. Trichrome stain revealed
bright blue collagen fibers in the adventitia surrounding
larger blood vessels and airways, delicate bands of colla-
gen beneath bronchial epithelium (see Figure 1E) and in
the pleura, and occasional thin strands within the alveolar
walls. The IL-12 KO mice exposed to sham-air also had
normal lung histology at all time points. Samples of the
spleen and the thymus were collected from all mice, and
appeared histologically normal in all cases. The mediasti-
nal/right paratracheal lymph nodes from mice exposed to
sham-air appeared normal in size and structure.
The effects of exposure to TiO2 were minimal, but detect-
able at all time points. Alveolar macrophages laden with
particles were notable at day 1 and appeared to be
increased in number. These cells were evident at 14, 42,
and 112 days as well. Other than increased numbers of
macrophages in the airspaces, the lungs of TiO2-exposed
mice appeared to be normal. The alveolar walls were not
thickened, collections of lymphocytes were not found,
and foci of fibroblasts or hypertrophic Type II alveolar
epithelial cells were not apparent. A representative section
from the lung of a mouse exposed to TiO2 112 days previ-
ously is shown in Figure 1B.
Inhalation of cristobalite silica caused pathological
responses that were evident by day 14 but not apparent as
early as day 1 in both the wild-type and IL-12 KO mice. In
contrast to the TiO2 exposure, increased numbers of mac-
rophages were not found 1 day after ending the 12 days of
exposure. The cristobalite particles are not birefringent or
visible by polarized light microscopy (as is quartz), thus
they cannot be seen readily by light microscopy. By 14
days post-exposure to silica the wild-type mice demon-
strated collections of inflammatory cells, scattered alveo-
lar exudates, and areas of hyperplastic Type II epithelial
cells. At 42 days after exposure more extensive lung tissue
changes, collections of lymphocytes surrounding small
airways and arterioles, and loose aggregates of fibroblast-
like cells were evident. These pathological features were
more pronounced by 112 days after exposure, and small
foci of increased connective tissue matrix material could
also be found (see Figure 1F). The lung pathology at 112
days is illustrated in Figures 1C and 1D. Trichrome stain
revealed bright blue bands of collagen fibers in alveolar
walls in silicotic lesions (Figure 1F). The silica-exposed IL-
12 KO mice at all time points demonstrated pathological
changes that were similar in quality and extent to those
found in the C57Bl/6 wild-type mice. The pathology was,
if anything, more extensive in the IL-12 KO mice than in
the wild-type animals, as shown in Figures 1G and 1H.
Pathology in wild-type and IL-12 knock-out Mice Figure 1
Pathology in wild-type and IL-12 knock-out Mice. This 
figure illustrates the lung pathology of C57Bl/6 wild-type and 
IL-12 KO mice 112 days after inhalation exposure to sham-
air, rutile titanium dioxide, or cristobalite silica. A lung sec-
tion from an air-exposed mouse shows normal histology (A, 
H&E, 400×). A lung section from a mouse exposed to TiO2 
(B, H&E, 400×) shows increased numbers of macrophages, 
and many of these cells are laden with particulates. No 
inflammatory foci are present, and the alveolar walls appear 
normal. Tissue from wild-type mice exposed to silica (C, 
H&E, 200×; D, H&E, 400×) show numerous patchy collec-
tions of macrophages and lymphocytes, with apparent hyper-
plastic alveolar epithelial cells and fibroblasts. Cuffs of 
lymphocytes surround some arterioles and airways. Tri-
chrome stain reveals bright blue connective tissue matrix and 
collagen (arrows) beneath the epithelium of the bronchial 
wall in a section from a sham-air exposed mouse (E), but 
rare matrix staining in the alveolar septae (400×). A silica-
exposed lung (F) shows bright blue trichrome stained matrix 
in alveolar walls (arrows) within a silicotic lesion (400×). Sec-
tions from silica-exposed IL-12 KO mice show typical fea-
tures of silicosis (G, H&E, 200×; H, H&E, 400×). The extent 
and features of disease are as intense as those found in the 
wild-type silica-exposed mice.Particle and Fibre Toxicology 2006, 3:2 http://www.particleandfibretoxicology.com/content/3/1/2
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The mediastinal/right paratracheal lymph nodes from
mice exposed to silica were greatly enlarged at 42 and 112
days after exposure in both the wild-type and IL-12 KO
mice. The microscopic pathology showed enlargement of
the germinal centers and the cortex, and increased num-
bers of germinal centers, as we have reported previously in
rodents [10,13].
The lung tissue sections from all mice (N = 40) were
graded for the extent of silicosis as described in Table 1.
Seventeen slides were graded twice in order to assess
observer reproducibility in scoring. No specimens in this
experiment averaged a score above 3.0, while previous
studies have shown occasional samples scoring as high as
4.0. Most of the slides scored twice had a difference of 0.5
or less between the first and second score (r = 0.62). The
pathology scores from the wild-type and the IL-12 KO
mice are shown in Figure 2. All of the lung sections from
C57Bl/6 mice exposed to sham air were scored as 0.6 or
less, and the air-exposed IL-12 KO mice were scored as 0.3
or less. The mice exposed to TiO2 scored 0.9 or less,
although they were recognizable because of particle-laden
macrophages. At 1 day post-exposure the wild-type mice
exposed to silica scored normally (0.3) and were indistin-
guishable from the sham-air specimens. Scores greater
than 1.0 were recorded for all silica-exposed samples after
1 day. The IL-12 KO mice exposed to silica were scored as
normal at 1 day, but had abnormal scores at all subse-
quent time points. The wild-type C57Bl/6 mice exposed
to silica scored significantly (ANOVA p < 0.05) higher
than air- or TiO2-exposed mice at 14, 42, and 112 days.
The silica-exposed IL-12 KO mice scored significantly
higher than their air-exposed litter mates at day 14, and
the differences approached significance (0.050 < p <
0.070) at days 42 and 112. The wild-type and the IL-12
KO mice exposed to silica tracked closely at all time
points, and there were no significant differences between
them.
Lung wet weight
The wet weight served as a crude indicator of the accumu-
lated mass of connective tissue matrix material, structural
cells, inflammatory cells, and edema fluid in the lung. The
right lung from each mouse was excised for collagen anal-
ysis, and was weighed immediately after removal from the
thorax. The values for right lung wet weight for each strain
and exposure group at the study time points are shown in
Figure 3. The wet weight of the right lung in sham-air
exposed wild-type mice increased over the 16 weeks of
observation (92.8 mg to 106.2 mg), a 14% increase com-
pared to a 40% increase in total body weight. The right
lung weights increased similarly in wild-type mice
exposed to sham-air or TiO2  and in IL-12 KO mice
exposed to sham-air. There were no significant differences
among the air or TiO2groups at any time after exposure.
The lungs of mice exposed to silica were increased in
weight at all time points. One day after the exposure
ended the lung wet weights from both wild-type and IL-12
KO mice were increased slightly, but the differences did
not reach significance. At days 14, 42, and 112 both silica-
exposed groups showed lung weights that were signifi-
cantly increased, and were approximately 65% greater
than the sham-air controls. There were no significant dif-
ferences between the silica-exposed wild-type and the IL-
12 KO mice at any time after exposure.
Lung collagen
The extent of pulmonary fibrosis was reflected by measur-
ing total lung collagen, assessed biochemically as the
quantity of hydroxyproline (OH-Pro) in the right lung.
The results from 5 mice in each group are shown in Figure
4. The amount of OH-Pro was greater in the lungs of sil-
ica-exposed mice at all time points after exposure, and the
differences reached significance at 14, 42, and 112 days.
There were no differences among the wild-type air-
exposed, wild-type TiO2-exposed, or the IL-12 KO air-
exposed mice at any time points. The IL-12 KO mice
exposed to silica had more lung OH-Pro at all four time
points. Thus silica exposure caused as much or more
excess collagen accumulation in the lungs of the IL-12 KO
mice as in the wild-type animals.
Table 1: Grading scale for silicosis in mice
Grade Degree Description
0 Normal histology Delicate alveolar walls, without inflammatory cells or alveolar exudates.
1 Minimal changes Increased numbers of macrophages, rare inflammatory cell collections, normal alveolar walls
2 Slight silicosis Occasional foci of macrophages and inflammatory cells, scattered areas of alveolar exudates, rare peribronchial and 
perivascular accumulations of lymphocytes.
3 Moderate silicosis Frequent foci with alveolar wall thickening, alveolar exudates, accumulations of inflammatory cells; hyperplastic Type 
II alveolar epithelial cells and collections of fibroblasts may be seen; some areas of lung may appear nearly normal.
4 Severe silicosis Almost the entire lung is obviously abnormal; numerous large accumulations of inflammatory cells, peribronchial and 
perivascular lymphocytes, alveolar remodeling.
Tissue sections were examined at 200× magnification and 10 microscopic fields were graded to generate an average score for each mouse.Particle and Fibre Toxicology 2006, 3:2 http://www.particleandfibretoxicology.com/content/3/1/2
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Cytokine gene expression
The intensity of gene expression for several cytokines of
interest was measured by ribonuclease protection assay.
Lung tissue samples from 3 mice from each strain and
exposure were analyzed at 1, 14, 42 and 112 days after
exposure. All of the samples and genes for each day were
measured simultaneously in a single hybridization, diges-
tion, and gel separation assay, and the results were
adjusted for the abundance of two constitutively
expressed genes (GAPDH, L32). The results for IL-12 p35
and IL-12 p40 gene expression are shown in Figure 5. IL-
12 p35 was expressed in low abundance at all time points
by both strains regardless of exposure history. There were
no significant differences among the various groups.
The IL-12 p40 subunit was expressed at low and consist-
ent levels by wild-type C57Bl/6 mice exposed to sham-air
or to TiO2 at all time points, with no differences due to
time or exposure. The wild-type mice exposed to silica
showed significant elevation of IL-12 p40 expression (p <
0.002) at all four time points, with greatest abundance at
112 days post-exposure. The IL-12 p40 subunit mRNA
was virtually undetectable in the IL-12 KO mice, as would
be expected since this is the gene that was modified to cre-
ate the strain [33].
The abundance of mRNA for interferon-γ (IFN-γ) is shown
in Figure 6. In both wild-type and IL-12 KO mice the
expression of IFN-γ appeared to be increased beyond 14
days after silica exposure compared to sham-air or TiO2-
exposed mice, and approached but did not reach signifi-
cance (0.05 < p < 0.070) at 112 days. There were no signif-
icant differences between the two strains; the IL-12 KO
mice appeared to up-regulate IFN-γ gene expression
despite the constitutive absence of IL-12 signaling.
We examined the expression of the interleukin-18 (IL-18)
gene, because this cytokine is known to augment the
effects of IL-12 in stimulating IFN-γ production [24,26].
The abundance of mRNA for IL-18 is shown in Figure 7 for
both wild-type and IL-12 KO mice. Message for this
cytokine was abundant in both strains of mice exposed to
sham-air or to TiO2 at all time points. The expression of
IL-18 mRNA was significantly decreased in mice exposed
to silica at the earlier time points (1 – 42 days), but was
normalized in C57Bl/6 mice 112 days after exposure.
There were no significant differences in IL-18 expression
between silica-exposed wild-type and IL-12 KO mice at
any time point.
IL-15 is an alternative cytokine produced in the lung that
could drive NK cell activation and up-regulate IFN-γ pro-
duction. IL-15 expression was tested in separate similar
experiments in which wild-type C57Bl/6 were exposed to
sham-air or cristobalite silica for 5 hours per day for 12
days. As shown in Figure 8, the mRNA expression of IL-15
was abundant in air-exposed mice and was increased




The C57Bl/6 wild-type mice exposed to crystobalite silica
developed pathological features of silicosis and progres-
sively increased total lung collagen that were closely simi-
lar to those we have reported previously in C3H/HeN
mice [8]. The IL-12 KO mice, also bred against a C57Bl/6
background, developed silicosis that was not distinguish-
able from that found in the wild-type animals. The mice
of both strains that were exposed to sham-air appeared to
be normal and had normal lung histology throughout the
experiment. We used exposure to rutile TiO2 as a compar-
ison for silica with a mineral particle expected to be bio-
logically relatively inactive and not cause pulmonary
fibrosis. Although the TiO2 did cause an increase in the
number of macrophages observed in the lung, and
numerous particles could be found in these cells, it did
not trigger recruitment of substantial numbers of lym-
phocytes, neutrophils, or other cell types, and it did not
cause an increase in lung collagen. These findings high-
light the inflammatory and fibrotic properties of silica
compared to other mineral particles, and demonstrate the
specific features of the response to inhaled silica.
Lung pathology score Figure 2
Lung pathology score. The extent of abnormality was 
graded semi-quantitatively in 10 areas of lung sections from 2 
mice in from each strain and exposure group at four time 
points. The data are shown as the average value, with individ-
ual scores shown as the range bar. The significance of differ-
ences among the groups is listed in the text.Particle and Fibre Toxicology 2006, 3:2 http://www.particleandfibretoxicology.com/content/3/1/2
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IFN-γ regulation in silicosis
Interferon-gamma (IFN-γ) is a potent pleomorphic
cytokine produced by activated T-lymphocytes, NK cells,
macrophages and possibly other cell types [34,35]. The
production of interferon-gamma (IFNgamma) in
response to infection is a hallmark of innate and adaptive
immunity, and its excessive release has been associated
with the pathogenesis of chronic inflammatory and
autoimmune diseases. Alterations in the abundance of
IFN-γ have been reported in silicosis by several investiga-
tors using inhalation or intra-tracheal (IT) instillation in
mice and rats, and in silica-exposed human workers.
Following inhalation exposure of C3H/HeN male mice
we observed increased mRNA for IFN-γ, localization of
IFN-γ mRNA transcripts to silicotic lung lesions and bron-
chial-associated lymphoid tissues (BALT), and increased
numbers of lymphocytes (natural killer (NK) cells, CD4+
and CD8+) producing IFN-γ protein [11,12]. In the
present study we observed expression of IFN-γ mRNA at
14 and 112 days, but not immediately (1 day), post expo-
sure in both wild-type and IL-12 KO mice (Figure 6). Hub-
bard and colleagues [36] performed IT instillation of 1 mg
quartz into NFκB-luciferase reporter mice, and studied the
responses at times up to 3 days after exposure. NFκB was
sharply increased in bronchial epithelial cells and macro-
phages; lung homogenate mRNA analysis showed
increased IFN-γ and IL-12 (p40) expression in response to
silica. Brown et al did not observe an increase in serum
IFN-γ or IL-12 proteins in NZM mice treated by intra-nasal
instillation with quartz, but did not measure lung or BAL
cytokine levels [37]. Garn and associates examined the
mediastinal lymph nodes of rats following silica inhala-
tion and observed node hypertrophy with a large increase
in the numbers of NK cells, CD4+ and CD8+ lymphocytes
and macrophages [10]. The level of IFN-γ and IL-12
mRNA were increased, while IL-4 mRNA was not
increased. Co-cultivation of macrophages and lym-
phocytes from silicotic nodes showed increased IFN-γ pro-
duction [13]. Conversely, Huaux and colleagues have
observed unchanged or decreased levels of IFN-γ mRNA in
mice instilled IT with quartz [15,38-40]. Increased serum
and urine levels of neopterin (a pteridine compound pro-
duced by human monocytes/macrophages upon stimula-
tion with IFN-γ [7001]) have been detected in silica-
exposed workers [41], implying up-regulation of IFN-γ in
human silicosis.
The abrogation of IFN-γ signaling has had varying effects
on silicosis in mice. When we exposed B6 mice to cristo-
balite silica inhalation and examined them 90 days later,
IFN-γ gene-deleted (KO) mice developed significantly less
extensive pathological changes and less collagen accumu-
lation than wild type mice [14]. Desaki et al performed IT
instillation of 2 mg of quartz into wild-type and IFN-γ KO
mice [42]. At 21 days after instillation, similar inflamma-
tory cell recruitment, lung pathology, and increased lung
OH-proline were found in both strains. Chen and col-
leagues treated rats by IT instillation of 20 mg of quartz
and then with daily intramuscular injections of human
recombinant IFN-γ [41]. At 1 or 2 months after silica expo-
sure the IFN-γ-treated rats showed lung pathology and
collagen accumulation that was intermediate between
saline-exposed and silica-exposed sham-cytokine ani-
mals, implying an anti-fibrotic effect from exogenous IFN-
γ treatment.
Interleukin-4 regulation in silicosis
Changes in IL-4 have been observed by some, but not all,
investigators studying silicosis. Huaux and associates
observed increased abundance of IL-4 signaling following
IT instillation of quartz [15,38-40] and modulation of
both the pathology and collagen accumulation in animals
where IL-4 abundance was increased or decreased in asso-
ciation with over-expression of IL-10 or IL-9 respectively.
Conversely, we did not find increased IL-4 mRNA or an
increase in the percentage of lymphocytes producing IL-4
in mice exposed to cristobalite by inhalation [11,12].
Garn and colleagues noted decreased IL-4 mRNA in the
lymph nodes of rats with silicosis [10,37]. Chen et al
found increased IL-4 mRNA in situ after silica instillation
into rats [43]. Desaki et al performed IT instillation of
Right lung wet weight Figure 3
Right lung wet weight. The wet weights (mg) of the right 
lungs from 5 mice in each strain and exposure group are 
shown at four time points after exposure. The data are 
shown as mean ± SD for each group. The wild-type and IL-12 
KO mice exposed to silica were significantly different (* = p 
< 0.002) from the sham-air exposed mice. There were no 
significant differences among the mice exposed to air or TiO2 
at any time point, or between the wild-type and IL-12 KO 
mice exposed to silica at any time pointParticle and Fibre Toxicology 2006, 3:2 http://www.particleandfibretoxicology.com/content/3/1/2
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quartz into wild-type and genetically modified mice that
lacked IL-4 (KO) [42]. Notably, the IL-4 deficient mice did
not show any reduction in the extent of lung pathology or
the accumulation of collagen.
IL-12 Biology
Interleukin-12, initially described as "cytotoxic lym-
phocyte maturation factor" or "NK cell stimulatory fac-
tor", is a heterodimeric cytokine that can act as a growth
factor for activated T-cells and NK-cells and can stimulate
the production of IFN-γ by resting mononuclear cells
[44,45]. The mature, biologically active secreted 70-kD
(p70) cytokine is produced by the covalent cross-linking
and glycosylation of two precursor chains encoded by
genes on separate chromosomes, the p35 and p40 subu-
nits. In mice, the p35 subunit is expressed in many lym-
phoid and non-lymphoid tissues including the lung,
while the p40 subunit is expressed in lymphoid cells [44]
and in airway epithelium [46]. The IL-12 related cytokines
consist of glycoproteins encoded by 5 independently reg-
ulated genes that combine as hetero- or homodimers to
produce 7 secreted proteins: IL-12 (the p40 and p35 het-
erodimer), p80 (a p40 homodimer), IL-23 (a p40 and p19
heterodimer), p40 monomer, and others [47]. Thus dele-
tion of the p40 gene will affect all of these molecules.
Biologically active IL-12 is produced predominantly by
macrophages, monocytes, and B-lymphocytes. Human
alveolar macrophages secrete IL-12 in response to stimu-
lation by endotoxin, IFN-γ, and other signals, with auto-
crine suppression by IL-10 [48]. IL-12 is produced
promptly during the induction of the adaptive cell-medi-
ated immune response to antigens and in response to
intracellular pathogens such as Myobacterium tuberculosis
or Listeria monocytogenes. Abundant IL-12 is an important
signal which biases the antigen-driven adaptive immune
response towards a TH1 (IFN-γ dominated) phenotype
rather than a TH2 (IL-4 dominated) phenotype
[45,49,50]. IL-12 drives target cells through a single high-
affinity receptor composed of two subunits [23]. Uncom-
mitted (TH0) T-cells and NK-cells appear to be the main
targets for IL-12.
Effects of IL-12 modulation
The biological functions of IL-12 have been tested in sys-
tems where the cytokine was augmented by injection,
blocked with antibody, removed by modification of the
p35 or p40 genes, or blocked by modification of the IL-12
receptor complex. In susceptible mouse strains treatment
with exogenous recombinant murine IL-12 reduced tuber-
culosis mortality [51], delayed mammary tumor onset
with reduced tumor burden [52], and inhibited hepatitis
B virus infection [53], apparently through the actions of
IFN-γ. Administration of IL-12 at the time of a single anti-
gen challenge abolished airway hyper-responsiveness and
pulmonary eosinophilia, and promoted increased IFN-γ
and decreased IL-4 and IL-5 expression, in mice sensitized
for asthma with ovalbumin [54].
Neutralization of IL-12 by the administration of antibody
greatly increased susceptibility of mice to primary infec-
tion with L. monocytogenes [55], protected BCG-primed
mice against a lethal response to endotoxin [56], and
reduced experimental immune colitis [57]. The IL-12 p40
gene-deleted strain (IL-12 KO used for this report) devel-
oped by Magram and colleagues [33] showed increased
susceptibility to infection with M. tuberculosis [58], Crypto-
coccus neoformans [59], and Leishmania major [60], and
showed diminished severity of collagen-induced arthritis
[61]. Wild-type C57BL/6 mice developed self-resolving
Leishmania chagasi infection with abundant IFN-gamma;
in contrast, L. chagasi disease was exacerbated and IFN-
gamma was low in IL-12KO mice [62].
Discoordinated production of IL-12 p40
The p40 gene subunit of IL-12 may be expressed and the
peptide product translated at high levels without coordi-
nate expression of the p35 subunit or production of the
complete p70 cytokine. Potentially, these products could
function as p80 homodimer or p40 monomer. In this
report we observed increased levels of p40 transcripts with
Total lung collagen Figure 4
Total lung collagen. The accumulation of collagen in the 
lung was assessed as the amount of OH-proline per right 
lung, with 5 mice in each group for each strain, exposure, and 
time point. The C57Bl/6 wild-type and the IL-12 KO mice 
exposed to silica had significantly more OH-Proline per right 
lung than the air- or TiO2-exposed mice at 14, 42, and 112 
days after exposure (* = p < 0.01). The differences between 
the IL-12 KO mice and the wild-type mice exposed to silica 
did not reach significance.Particle and Fibre Toxicology 2006, 3:2 http://www.particleandfibretoxicology.com/content/3/1/2
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no change in the abundance of p35 levels in mice exposed
to silica, as shown in Figure 5.
Soluble p40 peptide and/or homodimer appear to antag-
onize the biological actions of IL-12. IL-12 p40 transgenic
mice developed high serum levels of p40 monomer and
the homodimer p80 and exhibited increased susceptibil-
ity to intracellular pathogens and reduced delayed-type
hypersensitivity responses [63]. Over-expression of p40 in
transgenic mice diminished bladder carcinoma eradica-
tion [64] by IL-12. Over-production of p40 reduced TH1-
mediated myoblast allograft rejection [65], but did not
prevent the development of a TH1-like response in mouse
cardiac transplantation [66]. IL-12 p40 was intensely
over-expressed by airway epithelium in mice during para-
myxoviral bronchitis [46]. Patients with active systemic
lupus erythematosis show high serum levels of IL-12 p40
monomer without elevated p70 heterodimer levels [67].
These reports indicate that p40 can be produced discoor-
dinately from complete IL-12 p70 with substantial conse-
quences for immune-inflammatory responses.
Interleukin-23 (IL-23) is a dimer composed of the IL-12
p40 chain and a unique p19 chain that is related to but
not identical with IL-12 p35 [68]. IL-23 signals through a
dimeric receptor composed of the IL-12R-β1 chain joined
to a unique IL23R subunit, and acts through Jak-STAT sig-
naling as does IL-12 [69]. IL-23 induces proliferation of
selected T-cell populations and stimulates IFN-γ produc-
tion [68]. IL-23 is produced by dendritic cells and macro-
phages, and can be induced by viral infection [70]. It is
possible that the over-expression of IL-12 p40 that both
Interleukin-12 gene expression Figure 5
Interleukin-12 gene expression. The intensity of gene expression for both components of the IL-12 heterodimer was 
measured by ribonuclease protection assay in lung tissue samples from 3 mice from each strain and exposure condition. The 
results for C57Bl/6 wild-type mice are shown in the left panel and results for the IL-12 KO mice are shown in the right panel. 
The analysis for the IL-12 p35 subunit is shown in the upper panels and for the p40 subunit in the lower panels. The significance 
of the differences among the groups is presented in the text. The IL-12 p40 subunit mRNA was virtually undetectable in the IL-
12 KO mice because this is the gene that has been modified to create the knock-out strain.Particle and Fibre Toxicology 2006, 3:2 http://www.particleandfibretoxicology.com/content/3/1/2
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we and Huaux [71] observed in mice exposed to silica
could be destined for use as a component of IL-23, but IL-
23 was not measured in either study. Neither IL-12 nor IL-
23 must be critical for the development of silicosis or for
the induction of IFN-γ gene expression in mice exposed to
silica because IL-12 KO mice lacked p40 but showed both
silicosis and IFN-γ mRNA levels comparable to wild-type
mice.
Interleukin-12 in silicosis
Huaux and associates reported persistent over-production
of both IL-12 p40 protein and mRNA, but not IL-12 p70,
in female NMRI mice treated with quartz silica by IT instil-
lation [71]. They also compared female B6 mice with B6-
background IL-12 p35-/- mice that over-expressed p40,
and B6-background IL-12 p40-/- mice of the same strain
we used for the present report and treated the mice with
IT silica at 1 mg or 5 mg per mouse or saline [40]. At the
lower dose of silica the extent of silicosis (pathology, OH-
proline) was similar in the wild-type and the IL-12 p40-/-
mice, paralleling the results we report herein. At the
higher dose of silica the IL-12 p40-/- mice developed less
fibrosis than the wild-type mice, while the IL-12 p35-/-
mice developed more fibrosis than the wild-type mice.
When exogenous recombinant IL-12 p40 peptide was
administered 30 days after silica instillation, the amount
of fibrosis increased in both wild-type and IL-12 p40-/-
mice. They proposed that IL-12 p40 over-abundance
increased the intensity of the macrophage response to sil-
ica and the extent of fibrosis.
Our results and their findings with 1 mg quartz are similar
and supportive. Their findings with the 5 mg dose of
quartz suggest that the absence of IL-12 p40 may diminish
the response to silica at high doses. There are several dif-
ferences between our two test systems, as well as the sim-
ilarities noted. Huaux et al used a single IT instillation of
silica, while we used 12 days of inhalation exposure. The
IT dose could result in less uniform distribution of parti-
cles, and may allow larger particles to reach the alveolar
spaces than is permitted by aerodynamic filtration of
inhaled air. The particle size distribution used for the IT
instillation was not reported, while we used quite small
particles (Mass Median Aerodynamic Diameter 1.3 µm).
Huaux et al exposed mice to quartz silica, while we used
cristobalite silica for inhalation. We have reported previ-
ously the lung burden of silica retained immediately and
at selected times after inhalation of cristobalite [8], while
the lung burden following intratracheal quartz was not
described. Our last time point was 112 days, while theirs
was 60 days. They used female mice, while we used male
mice. It is likely that the difference between our results
and theirs (less silicosis in IL-12 p40-/- with higher doses
of silica) can be explained by these differences in experi-
mental design.
Macrophages respond to a variety of chemotactic signals,
such complement C5a, MCP-1 (CCL2), MIP-1α (CCL3),
p80, and other mediators. These signals appear to be
highly redundant, although each may act in a slightly dif-
ferent manner or at a different stage in the process of mac-
rophage migration. A large literature supports the
importance of blocking or deleting one or more of these
chemokines in specific diseases. Russell and colleagues
showed the importance of IL-12 p80/Rβ1 signaling, but
not IL-12 or p40 monomer signaling, for lung macro-
phage recruitment during murine Sendai virus infection
[72]. Huaux and associates [40] showed decreased recruit-
ment of macrophages, neutrophils and lymphocytes fol-
lowing IT instillation of silica into IL-12 p40 KO mice,
and attributed the effect to the absence of p80
homodimer. In the present study we did not observe any
obvious changes in the abundance of macrophages in the
lung lesions of IL-12 KO mice exposed to silica, and the
overall extent of the pathology, the lung wet weight, and
the increase in collagen were not reduced compared to
wild-type mice. Bronchoalveolar lavage was not per-
formed in these studies, and thus pulmonary macro-
phages were not quantified directly. Our results imply that
p80 is not essential for the expression of silicosis, but do
not indicate whether or not this chemokine may contrib-
ute to macrophage recruitment in silicosis in normal
mice.
Interferon-γ gene expression Figure 6
Interferon-γ gene expression. The abundance of mRNA 
for interferon-γ (IFN-γ) is shown for the wild-type (upper 
panel) and IL-12 gene-deleted (lower panel) mice.Particle and Fibre Toxicology 2006, 3:2 http://www.particleandfibretoxicology.com/content/3/1/2
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IL-18 biology
Interleukin-18 (IL-18) is a member of the IL-1 family that
augments the activity of IL-12 in the generation of TH1-
type immune responses [73]. It cannot act alone to induce
IFN-γ production, but rather acts in concert with IL-12 to
produce this effect. We surveyed this cytokine because we
postulated that it might contribute to the increased IFN-γ
production we reported previously [11,12]. IL-18 mRNA
abundance was decreased in wild-type mice at early time
points following silica exposure, and was at normal levels
at 112 days. Like IL-15 or IL-12 p40, and in contrast to IL-
12 p35, IL-18 mRNA appeared to be produced constitu-
tively at moderate levels in air-exposed mice of both
strains. We examined the abundance of IL-18 message
because this cytokine can augment the effects of IL-12,
and may be an important signal to bias TH1 or TH2 polar-
ization [74,75]. It has pleotrophic and sometimes para-
doxical effects [75]. As shown in Figure 7, we did not find
it up-regulated at an mRNA transcript level. IL-18 is pro-
duced as an inactive pro-peptide that must be cleaved by
caspace-1 to achieve a biologically active form. Thus, IL-
18 is regulated at a post-translational level as well as
through transcription. The factors that augment or inhibit
IL-18 production are largely unknown. We do not have an
explanation for why mRNA abundance is decreased after
silica exposure. These observations suggest that IL-18 may
not be an important stimulus towards a TH1-like response
or for IFN-γ production in silicosis. Experiments augment-
ing, blocking, or deleting IL-18 active protein would be
needed in order to test its role directly.
Mechanisms of silicosis: innate versus adaptive immunity
There appears to be a complex cytokine network through
which macrophages, lymphocytes, fibroblasts, and other
cell types interact to produce characteristic pathological
responses to silica in the lung. While the pivotal function
of macrophages in silicosis has been highlighted, the roles
that might be played by lymphocytes in this process are
less clear [1-7,14]. Brown and associates found increased
CD4+ T-cells and a TH1-like phenotype following intrana-
sal quartz in New Zealand Mixed mice, a strain prone to
autoimmune disease. Hubbard reported no decrease in
silicosis in T-cell deficient "nude" (Balb/cnu/nu) mice [76],
while Barbarin and colleagues observed decreased silico-
sis in mice treated with anti-CD4 antibody [15].
The initial adaptive immune response to infection or anti-
gens is usually driven towards either a T-helper type 1
(TH1) or a T-helper type 2 (TH2) phenotype [77,78]. The
TH1 phenotype dominates the response to intracellular
pathogens such as Mycobacterium tuberculosis and features
intense production of IFN-γ, believed to be driven by IL-
12 and enhanced by IL-18 [24,34,79]. The TH2 phenotype
is featured in responses to parasitic infections and is
prominent in allergic responses, with IL-4, IL-5, and IL-13
as abundant cytokines. These two types of responses were
believed originally to be mutually exclusive: IFN-γ sup-
presses T-cell production of IL-4 and drives T-cells towards
a TH1 phenotype, while IL-4 has the opposite effect.
Unfortunately, this categorical classification is often
blurred in complex or chronic diseases, and features of
both a TH1 and a TH2 response may be found simultane-
ously [80]. IFN-γ activates uncommitted NK cells, T-cells,
and macrophages, but inhibits fibroblast proliferation
and responsiveness to transforming growth factor-beta
(TGF-β). IL-4 may also activate uncommitted lym-
phocytes, and IL-13 enhances fibroblast collagen produc-
tion driven by TGF-β. Current theory proposes that in the
lung TH2-like responses appear to enhance fibroblast pro-
liferation and collagen production, while TH1-like
responses are pro-inflammatory but may be anti-fibrotic
[81,82]. The TH1/TH2 paradigm was derived from analysis
of T-lymphocytes participating in an infectious or allergic
disease. It is now clear that many cell types in addition to
T-cells can produce IL-4, IL-13, IFN-γ, and other relevant
cytokines. Macrophages, bronchial epithelial cells, and
possibly alveolar Type II pneumocytes may be additional
sources for these mediators. How can we apply these the-
ories to the pathogenesis of silicosis and resolve some of
the conflicting data regarding the abundance and role of
IFN-γ, IL-4 or IL-12?
Interleukin-18 gene expression Figure 7
Interleukin-18 gene expression. The abundance of 
mRNA for IL-18 is shown for the wild-type (upper panel) and 
the IL-12 gene-deleted (lower panel) mice. The expression of 
IL-18 was significantly decreased at earlier time points after 
silica exposure in both strains (* = p < 0.01), but normalized 
by 112 days.Particle and Fibre Toxicology 2006, 3:2 http://www.particleandfibretoxicology.com/content/3/1/2
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An alternative, rapid, and more primitive reaction path-
way to toxic substances and invading pathogens is the
innate immune response [83,84]. It is not antigen-spe-
cific, and does not require MHC-restricted antigen presen-
tation. The innate immune response would be a likely
pathway for silicosis, since silica is not apparently an anti-
gen, and there is no evidence for an immunospecific
response to it. The innate immune response can also
involve up-regulation of IFN-γ production by natural
killer cells and other lymphocytes through the actions of
IL-15 [28,85-87]. IL-15 is critical to the bone marrow pro-
liferation and peripheral organ function of NK cells
[28,87-90]. IL-15 participates in lung inflammation, and
is essential for the local pulmonary maintenance and acti-
vation of NK cells [31,85,91]. Mice that are deficient in IL-
15 do not generate mature NK cells, and lack critical
innate host defense and tumor defense functions [92]. IL-
15 can drive IFN-γ production in NK cells and T-lym-
phocytes, and provides a signal pathway to bias the innate
immune response towards a TH-1-like phenotype. We
observed substantial IL-15 mRNA in the lung tissues from
air-exposed mice and slight up-regulation of IL-15 in sil-
ica-exposed, as shown in Figure 8. This finding supports
the concept that IL-15 could be an essential driving mech-
anism in lymphocyte activation and IFN-γ production in
silicosis.
Silicosis is not an antigen-driven adaptive immune
response to a specific antigen, pathogen, or allergen. It
appears to be a chronic innate immune response in which
the offending agent, silica, is persistent indefinitely but is
not antigenic. T-lymphocytes are not essential, or play a
minor amplifying role [76]. Kunkel [81] has proposed
that chronic immune-mediated lung diseases follow
sequential stages: (1) an initial innate immune response
to foreign challenge, (2) an acquired immune stage with
first a TH1-like response followed by a TH2-like response,
and finally (3) a repair phase with fibroblast proliferation
and collagen deposition. Strieter and Keane [82] have
invoked the concept that a TH1-like response may favor
resolution of injury and inflammation, while a TH2-like
response may lead to progressive fibrosis. Silicosis may fit
squarely within this paradigm. Although there is no evi-
dence for true antigen-specific TH1 or TH2 response in sili-
cosis, increased levels of IFN-γ, IL-4, and other cytokines
may create a TH1-like or TH2-like local milieu. Because
biologically active IL-12 p70 protein does not appear to be
either increased or essential (this report, Huaux and col-
leagues), other mechanisms must be invoked to drive
IFN-γ production, NK cell activation, and the aspects of
the process that resemble the TH1 response. We propose
IL-15 as a candidate for this role. The primarily signals
that might induce IL-4 or IL-13 in silicosis have not been
identified.
We suggest that the innate immune response to silica par-
ticles persists and evolves over time. With human expo-
sure over a working lifetime, newly inhaled particles may
repeatedly initiate the cycle, while older sequestered mate-
rial may drive progressive fibrosis. It is likely that the
higher the dose the more extensive the initial injury and
the more rapidly the responses may cycle through the
phases outlined above. With IT instillation of silica the
initial phases of macrophage response and TH1-like
cytokines may pass very quickly, and may only be cap-
tured at early time points (note the up-regulation of IFN-
γ mRNA found by Hubbard et al [36] at 4 and 24 hours).
The chronic fibrotic TH2-like phase dominated by IL-4
and IL-13 may be in ascendance very soon after IT expo-
sure, and the TH1-like response may no longer be appar-
ent. When rodents are exposed by inhalation a lower dose
of silica is applied. This may extend the initial phase of the
response by resident macrophages, and may allow the
early TH1-like response with IFN-γ to continue for at least
4 months, as we have observed. We postulate that in both
model systems a transition would occur from the TH1- to
the TH2-like response; the higher the dose of silica, the ear-
lier the transition. These responses could be quite local-
ized within the lung, such that some early silicotic lesions
with many recruited mononuclear cells have abundant
IFN-γ while more advanced fibrotic lesions are dominated
by IL-4. As noted above, T-lymphocytes and NK cells may
Interleukin-15 gene expression Figure 8
Interleukin-15 gene expression. The expression of IL-15 
was measured in C57Bl/6 mice 14 and 42 days after exposure 
to sham-air or cristobalite silica. Data are shown as mean ± 
SD for 3 samples per group. The inset from 14 days post-
exposure shows the polyacrilamide gel bands for IL-15 
mRNA transcripts and the comparison ubiquitous gene 
GAPDH from the air- (A) and silica- (S) exposed lungs.Particle and Fibre Toxicology 2006, 3:2 http://www.particleandfibretoxicology.com/content/3/1/2
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not be the only sources for these cytokines, and structural
lung cells may contribute to the signaling as well.
We view IFN-γ as having an amplifying role on inflamma-
tory cells in the initial phases of silicosis. Macrophages
responding to silica and recruited NK cells and T-cells
responding to macrophage chemotactins may produce
IFN-γ, leading to subsequent further macrophage and
lymphocyte activation. In this manner abundant IFN-γ
early in the response to silica may exacerbate inflamma-
tion and cause a net increase in early collagen deposition,
while the absence of IFN-γ may reduce the extent of the
initial pathology and lead to less early collagen deposition
as we observed [14]. IFN-γ might also have a modulating
anti-fibrotic role in the later responses by suppressing
fibroblast proliferation and inhibiting IL-4 production. If
the initial dose of silica is high, then TH2-like responses
may dominate from the outset [42].
Because IFN-γ is abundant in mice exposed to silica [11-
13], and mice with the IFN-γ gene deleted develop less sili-
cosis than IFN-γ-sufficient mice [14], we believe that IFN-
γ is an important mechanistic pathway in silicosis. The
pathways leading to IFN-γ production during intracellular
pathogen infection and following exposure to antigens
that induce a TH1-type response favor IL-12 and IL-18 pro-
duced by macrophages and other cell types [24,34,79].
This sequence is an important pathway in the adaptive
immune response.
Conclusion
We conclude that the axis of IL-12 driving lymphocyte
activation and IFN-γ production, the primary adaptive
immune response pathway towards a TH-1 phenotype, is
not essential for the full manifestations of silicosis in mice
exposed to a crystobalite silica aerosol. It is likely that IL-
18 is not a major contributor to this response either, since
IL-18 mRNA was not increased following silica exposure
and IL-18 is not sufficient alone to trigger IFN-γ produc-
tion [73]. Pathways other than IL-12 and IL-18 appear to
be driving lymphocyte activation and recruitment and
IFN-γ production in silicosis, with IL-15 a likely candi-
date. This concept implies that silicosis is a chronic innate
immune-inflammatory response that does not convert to
adaptive immune response pathways over time. More
research is required in order to explore these mechanisms.
Methods
Inhalation exposure of mice
Wild-type C57Bl/6 (WT) and Interleukin-12 deficient (IL-
12 KO) male mice were purchased from The Jackson Lab-
oratory, Bar Harbor. ME at 6 weeks of age, and were
housed in positive-pressure pressure barrier housing units
(Thoren, Hazelton, PA) with mouse chow and water pro-
vided ad libitum. The IL-12 KO mice were developed by
Jeanne Magram [33] and were available commercially
(Jackson Stock No. 002693; B6.129S1-Il12b  tm1jm). The
mice were exposed by inhalation in separate chambers for
5 hours per day for 12 days to sham-air, rutile titanium
dioxide (TiO2, MMAD = 0.5 µm) at 72 mg/m3 ± 30 mg/m3
(mean ± SD) or cristobalite silica (MMAD = 1.3 µm) at 61
mg/m3 ± 16 mg/m3. The chambers utilized horizontal
flow temperature- and humidity-conditioned HEPA-fil-
tered air with continuous environmental monitoring and
daily gravimetric measurements of ambient dust concen-
trations. The WT mice were exposed to air or TiO2 or silica
and, simultaneously, the IL-12 KO mice were exposed to
air or silica. The characteristics of the exposure system and
the features of silicosis in mice exposed under these con-
ditions have been described in detail [8,93,94].
Study schedule & organ harvest
Groups of 5 mice were studied for each strain, exposure
condition, and time point. Mice were studied 1, 14, 42,
and 112 days after the exposure was completed. Mice were
killed by intra-peritoneal injection of sodium pentobarbi-
tal (200 mg/kg). Two animals in each group had the tra-
chea cannulated, the thorax opened, the inferior vena cava
and aorta transected, the right lung cross-clamped at the
hilum and the left lung inflated with 4% paraformalde-
hyde at 10 cm H2O pressure, and held for 3 minutes. The
isolated right lung was removed, weighed, and frozen
immediately for OH-Pro analysis (total lung collagen).
The inflated left lung was removed, fixed for 24 hours in
4% paraformaldehyde at room temperature, then trans-
ferred to 70% ethanol and held at 5°C. The fixed lung
specimens were embedded in paraffin, sectioned at 4 µm,
and stained with hematoxylin and eosin (H&E) for micro-
scopic examination. Three mice in each group had the
thorax opened immediately, the right lung removed,
weighed, and frozen for hydroxyproline analysis, and the
left lung removed, weighed, and immediately plunged
into liquid nitrogen. The frozen left lung specimens were
held at -80°C until mRNA was extracted and analyzed.
Thus, in each group there were 5 samples for lung colla-
gen, 3 samples for mRNA abundance, and 2 specimens for
histopathology.
Histopathology
Lung tissue sections stained with H&E were examined by
light microscopy at 40- to 400-fold magnification. A semi-
quantitative 5-level lung pathology score was used to
grade the extent of abnormalities in each microscopic
field at 200×. The grading scale is shown in Table 1. The
labels of the slides from the lung sections were masked
and presented in random order for scoring by one investi-
gator (GSD). Ten microscopic fields with lung paren-
chyma were scored and averaged to generate a composite
score for each mouse. Approximately 1 in 10 of the slides
was recycled for repeat scoring to assess intra-observer var-Particle and Fibre Toxicology 2006, 3:2 http://www.particleandfibretoxicology.com/content/3/1/2
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iation. The average of these two scores was used for mice
that were scored twice. Lung tissue sections were stained
with Masson's Trichome to reveal fibrillar collagen and
connective tissue matrix proteins, and were photographed
by light microscopy at 400× original magnification.
Lung collagen
Total lung collagen for the right lung of each mouse was
estimated by measuring the OH-Pro content by colorimet-
ric assay, as previously described [8]. Briefly, the right lung
was dried for 24 hours at 60°C, powdered with pestle, and
weighed. Half the powder was digested in 6N HCl at
110°C for 18 hours, neutralized with 6N NaOH, reacted
with chloramine-T solution, perchloric acid and Ehrlich's
reagent, and the optical density of the solution measured
at 560 nm. Serial dilutions of trans-hydroxy-L-proline
were used to prepare a standard curve for comparison. The
results were expressed as µg OH-Pro per right lung.
Cytokine gene expression
The abundance of mRNA for cytokine genes of interest
was assessed using a commercial ribonuclease protection
assay (Riboquant gene sets mCK-1b and mCK-2b, BD Bio-
sciences Pharmingen, San Diego, CA). The mRNA from
the left lung specimens was extracted in Trizol (Life Tech-
nologies, Grand Island, NY) and purified through 100%
cold ethanol. The kit mixture of cDNA oligomers was tran-
scribed as anti-sense mRNA with radiolabeling with 32P-
UTP. Alliquots of lung total RNA were reacted with the
labeled mixture of anti-sense mRNA's, digested with
RNase, applied to the lanes of a polyacrylamide vertical
gel, electrophoresed through tris-borate-EDTA buffer to
separate undigested protected fragments, and the gel dried
for 1 hour. A film sheet (Kodak, Biomax MR) was applied
to the gel and exposed for 18 hours at -80°C for visualiza-
tion of bands. The gel was then applied to an imaging
screen and the density of each band read in a phosphoim-
ager (Bio-Rad, Hercules, CA). The expression of IL-12 p40,
IL-12 p35, IL-15, IL-18, and interferon-gamma (IFN-γ)
were examined for this report. Probes for L32 and glycer-
aldehyde-3-phosphate dehyrogenase (GAPDH) were
included in the mixture as reference standards for consti-
tutively expressed genes not expected to change in abun-
dance. The phosphoimager density for each cytokine
band was adjusted for the abundance of GAPH and L32 in
the same lane by averaging the latter two values, dividing
the cytokine value by the average, and multiplying the
result by 100. The 3 values from the mice in each strain/
exposure/time point group were averaged to express a
mean value for each cytokine of interest.
Statistics
Data for all variables were expressed as mean ± SD. Differ-
ences among groups due to strain, exposure, or time after
exposure were assessed by one-way analysis of variance
(ANOVA) with post-hoc testing by the Bonferroni method
(Systat v10, SPSS, Inc, Chicago, IL).
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